iRhythm Technologies, Inc. (NASDAQ: IRTC)
Hagens Berman Sobol Shapiro LLP alerts investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) to the firm's investigation into possible securities law violations.
If you purchased or otherwise acquired securities of IRTC before March 27, 2019 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing IRTC@hbsslaw.com.
Between March 13, 2019 and March 27, 2019, certain analysts began publicly questioning (a) the sustainability of third party reimbursements to the Company attributable to sales of its Zio XT Extended Holter patch device, (b) whether the Company’s and management’s statements about the total addressable market for iRhythm products may have been misleading, and (c) whether the Company and management may have used “cookie jar” style accounting in accruing for bad debt expense and contractual allowances.
During the period in which these reports were published, the price of iRhythm shares has significantly fallen.
“We’re focused on investors’ losses, the matters raised in the reports, and whether investors may have been misled,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.